Actrapid HM Penfill (3ml Each) is a short-acting insulin used for managing type 1 and type 2 diabetes mellitus. It is prescribed alongside a healthy diet and regular exercise to regulate blood sugar levels after meals, thereby preventing serious diabetes-related complications such as kidney damage and blindness. Typically, Actrapid HM Penfill is used in combination with a long-acting insulin or other diabetes medications. Your doctor or nurse will guide you on the correct way to inject it under the skin, and it should be administered 20-30 minutes before a meal. This insulin therapy is only one part of an overall diabetes management plan, which should also include a balanced diet, physical activity, and weight control as recommended by your doctor. Regular monitoring of blood sugar levels is crucial to determining the appropriate dosage and ensuring effective treatment.

The most common side effects of Actrapid HM Penfill include low blood sugar (hypoglycemia), injection site reactions, cold sweats, anxiety, shakiness, hunger, rapid heartbeat, headache, and nervousness. Hypoglycemia is more likely to occur if meals are skipped after taking the injection, so it is important to adhere to a proper meal schedule. Excessive alcohol consumption can also lower blood sugar levels. Other possible side effects include redness or swelling at the injection site, and some individuals may experience weight gain while on insulin therapy. This medication should not be used if you have low blood sugar levels. Before starting treatment, inform your doctor if you have a history of kidney, liver, or heart problems. Pregnant or breastfeeding women should also seek medical advice, as dosage adjustments may be necessary.